Senior Director, Head of Translational Research Hematology & CVR

egy, scientific expertise and leadership in the direction, growth and continued development of all aspects of Translational Research. Working with the Research and clinical bioanalytics function and clinical development, you will advocate for the generation, delivery, endorsement and implementation of high quality, peer-reviewed bioassay and biomarker strategies/plans to provide pre-clinical and scientific data to support important pre-clinical Toxicology studies and improve clinical development programs.

As part of the Translational and Data Science leadership team you will

• Develop and implement a Translational Framework including both forward and reverse translational approaches to refine research strategies and enhance clinical development pathways.

• Lead and mentor a diverse team of cell biologists and biochemists to foster a culture of innovation and excellence

• Lead translational research of preclinical findings into clinical applications, ensuring scientific discoveries are developed into therapeutic solutions

• Oversee the planning, execution, budget and reporting of translational science projects

Your experience

• Industry experience across one or more of the following areas - haematology, cardiovascular and/or renal

• Proven leader with an ability to lead, motivate and drive successful research programs from bench to clinic

• Evidence of contribution to the development of drug candidates

• Experience working with external partners in clinical translational science, academia and other industry groups

• Understanding of bioinformatics tools, data analysis techniques, and translational research methodologies

Apply now to join a global biotherapeutics leader leading the way on serious and rare diseases!

Our Benefits

We encourage you to make your well-being a priority. It's important and so are you. Learn more about how we care at CSL.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

We want CSL to reflect the world around us

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL.

Do work that matters at CSL Behring!